Comprehensive genomic evaluation for complex cases. GenoXome delivers high-resolution whole exome sequencing, providing strong diagnostic support across a wide spectrum including rare diseases, neurodevelopmental disorders, neuromuscular pathologies, and inherited cancer risks.

Multidimensional analysis in a single test. In addition to detecting SNVs, indels, and large-scale structural variants within exonic regions, GenoXome can simultaneously evaluate copy number variations (CNVs) and mitochondrial DNA (mtDNA) variants, elevating the test to an advanced level of analytical coverage.

Quality-assured workflow. All laboratory and analytical processes are conducted under ISO-based quality management systems and supported by a CE-IVD–compliant testing infrastructure with a fully validated bioinformatics pipeline.

Robust clinical database support. Diagnostic accuracy is enhanced through the use of an extensive database integrating scientific literature, clinical guidelines, population datasets, and phenotype–genotype correlations for variant interpretation.